Induction of lepromin positivity following immuno-chemotherapy with Mycobacterium w vaccine and multidrug therapy and its impact on bacteriological clearance in multibacillary leprosy: Report on a hospital- based clinical trial with the candidate antileprosy vaccine

International Journal of Leprosy and Other Mycobacterial Diseases

Volumn 67, Issue 3, 1999, Pages 259-269

  Sharma, Pankaj ^a   Kar, Hemant K ^b   Misra, Radhey S ^c   Mukherjee, Ashok ^c   Kaur, Harvinder ^a   Mukherjee, Rama ^a   Rani, Rajni ^a  

^a NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

^b DR RAM MANOHAR LOHIA HOSPITAL   (India)

^c SAFDARJUNG HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CLOFAZIMINE; DAPSONE; LEPROMIN; LEPROSY VACCINE; RIFAMPICIN;

ANTIBIOTIC THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; HUMAN; IMMUNOTHERAPY; LEPROMIN TEST; LEPROSY; MAJOR CLINICAL STUDY; VACCINATION;

BACTERIAL VACCINES; CLOFAZIMINE; DAPSONE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; HUMANS; IMMUNOTHERAPY; LEPROMIN; LEPROSTATIC AGENTS; LEPROSY; MYCOBACTERIUM LEPRAE; RIFAMPIN; SINGLE-BLIND METHOD; SKIN TESTS; VACCINES, INACTIVATED;

EID: 0032749379     PISSN: 0148916X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. CHAUDHURY, S., HAJRA, S. K., MUKHERJHE, A., SAHA, B., MAJUMDAR, V., CHATTAPADHYA, D. and SAHA, K. Immunotherapy of lepromin-negative borderline leprosy patients with low-dose Convit vaccine as an adjunct to multidrug therapy; a 6-year follow-up study in Calcutta. Int. J. Lepr. 65 (1997) 56-62.
2. CONVIT, J., ARANZAZU, N., ULRICH, M., ZUNIGA, M., DE ARAGON, M. E., ALVARADO, J. and REYES, O. Investigations related to the development of a leprosy vaccine. Int. J. Lepr. 51 (1983) 531-539.
3. CONVIT, J., PINARDI, M. E., RODRIGUEZ-OCHOA, G., ULRICH, M., AVILA, J. L. and GOIHMAN-YAHR, M. Elimination of Mycobacterium leprae subsequent to local in vivo activation of macrophages in lepromatous leprosy by other mycobacteria. Clin. Exp. Immunol. 17 (1974) 261-265.
4. CONVIT, J., SAMPSON, C. and ZUNIGA, M. Immunoprophylactic trial with combined Mycobacterium leprae/BCG vaccine against leprosy: preliminary results. Lancet 1 (1992) 446-450.
5. DHARMENDRA. The lepromin test. In: Leprosy Vol. 2. Bombay: Samant & Co., 1985, pp. 999-1063.
6. DHARMENDRA and CHATTERJEE, K. R. Prognostic value of lepromin test in contacts of leprosy cases. Lepr. India 27 (1955) 149-157.
7. DHARMENDRA and LOWE, J. Studies of the lepromin test (6). Results of Mitsuda test in cases of leprosy of different clinical types. Lepr. India 14 (1942) 3-12.
8. FERNANDEZ, J. M. M. The early reaction induced by lepromin. Int. J. Lepr. 8 (1940) 1-8.
9. GUPTE, M. D., ANANTHARAMAN, D. S., DE BRITTO, R. L. J., VALLISHAYEE, R. S., NAGARAJU, B., KANNAN, S. and SENGUPTA, U. Sensitization potential and reactogenicity of BCG with and without various doses of killed Mycobacterium leprae. Int. J. Lepr. 60 (1993) 340-352.
10. GUPTE, M. D., VALLISHAYEE, R. S., ANANTHARAMAN, D. S., DE BRITTO, R. L. J. and NAGARAJU, B. Sensitization and reactogenicity of two doses of candidate antileprosy vaccine Mycobacterium w. Indian J. Lepr. 68 (1996) 315-324.
11. KATOCH, K., KATOCH, V. M., NATRAJAN, M., BHATIA, A. S., SREEVATSA, GUPTA, U. D., SHARMAN, V. D., SHIVANNAVAR, C. T., PATIL, M. A. and BHARDWAJ, V. P. Treatment of bacilliferous BL/LL cases with combined chemotherapy and immunotherapy. Int. J. Lepr. 63 (1995) 202-211.
12. MAJUMDAR, V., MUKHERJEE, A., HAJRA, S. K., SAHA, B. and SAHA, K. Immunotherapy of far-advanced patients of lepromatous leprosy with low-dose Convit vaccine along with MDT (Calcutta trial). Int. J. Lepr. 64 (1996) 26-36.
13. NAIK, S. S. and NORE, P. R. The pattern of "dropouts" of smear-positive cases at an urban leprosy center. Indian J. Lepr. 68 (1996) 161-166.
14. PONNIGHAUS, J. M., FINE, P. E. M., STERNE, J. A. C., WILSON, R. J., MSOSA, E., GRUER, P. J. K., JENKINS, P. A., LUCAS, S, B., LIOMBA, N. G. and BLISS, L. Efficacy of BCG vaccine against leprosy and tuberculosis in north Malawi. Lancet 1 (1992) 636-639.
15. RADA, E. M., CONVIT, J., ULRICH, M., GALLINOTTO, M. E. and ARANZAZU, N. Immunosuppression and cellular immunity reactions in leprosy patients treated with a mixture of Mycobacterium leprae and BCG. Int. J. Lepr. 55 (1987) 646-650.
16. RADA, E., ULRICH, M., ARANZAZU, N., SANTAELLA, C., GALLINOTO, M. E., CENTENO, M., RODRIGUEZ, V. and CONVIT, J. A longitudinal study of immunologie reactivity in leprosy patients treated with immunotherapy. Int. J. Lepr. 62 (1994) 552-558.
17. RADA, E., ULRICH, M., ARANZAZU, N., RODRIGUEZ, V, CENTENO, M., GONZALEZ, I., SANTAELLA, C., RoDRIGUEZ, M. and CONVIT, J. A follow-up study of multibacillary Hansen's disease patients treated with multidrug therapy (MDT) or MDT + immunotherapy (IMT). Int. J. Lepr. 65 (1997) 320-327.
18. SHARMA, P., KAR, H. K., MISRA, R. S., MUKHERJEE, A., KAUR, H., MUKHERJEE, R. and RANI, R. Disabilities in multibacillary leprosy following MDT with and without immunotherapy with Mycobacterium w antileprosy vaccine. Int. J. Lepr. 67 (1999) 250-258.
19. TALWAR, G. P., ZAHEER, S. A., MUKHERJEE, R., WALIA, R., MISRA, R. S., SHARMA, A. K., KAR, H. K., MUKHEKJEE, A., PARIDA, S. K., SURESH, N. R., NAIR, S. K. and PANDEY, R. M. Immunotherapeutic effects of a vaccine based on a saprophytic cultivable mycobacterium, Mycobacterium w, in multibacillary leprosy patients. Vaccine 8 (1990) 121-129.
20. THUC, N. V., ABEL, L., LAP, V. D., OBERTI, J. and LAGRANGE, P. H. Protective effect of BCG against leprosy and its subtypes: a case-control study in southern Vietnam. Int. J. Lepr. 62 (1994) 532-538.
21. VALLISHAYEE, R. S., GUPTE, M. D., ANANTHARAMAN, D. S. and NAGARAJU, B. Post-vaccination sensitization with ICRC vaccine. Indian J. Lepr. 68 (1996) 167-174.
22. WATERS, M. F. R., RIDLEY, D. S. and LUCAS, S. B. Positive Mitsuda response in long-term treated lepromatous leprosy. Lepr. Rev. 61 (1990) 347-352.